These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7318924)

  • 41. Mode of action of Emcyt.
    Høisaeter PA
    Urology; 1984 Jun; 23(6 Suppl):46-8. PubMed ID: 6375079
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment of oral estramustine phosphate (Estracyt) in prostatic carcinoma: influences on lipid and carbohydrate metabolism.
    Gustafson A; Persson B; Tisell LE; Wiklund O; Ohlson R
    Invest Urol; 1977 Nov; 15(3):220-4. PubMed ID: 591268
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Subcellular localization of estramustine in rat ventral prostate following intravenous injection.
    Peterson C; Forsgren B; Högberg B
    Acta Physiol Scand Suppl; 1983; 515():55-63. PubMed ID: 6578672
    [No Abstract]   [Full Text] [Related]  

  • 44. Estramustine phosphate-reduced proliferation of murine and human cell lines and murine transplantable tumors.
    Pavelić K; Zgradić I; Osmak M; Popović M
    Res Exp Med (Berl); 1985; 185(3):233-43. PubMed ID: 3860896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estramustine phosphate: metabolic aspects related to its action in prostatic cancer.
    Kadohama N; Kirdani RY; Murphy GP; Sandberg AA
    J Urol; 1978 Feb; 119(2):234-9. PubMed ID: 633484
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Binding sites for the cytotoxic metabolites of estramustine phosphate (Estracyt) in rat and human pancreas that are distinct from pancreatic estrogen-binding protein.
    Björk P; Jönsson U; Andrén-Sandberg A
    Pancreas; 1991 Jan; 6(1):77-89. PubMed ID: 1994382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of castration on the smooth muscle cells of the internal sex organs of the rat: influence of the smooth muscle on the sympathetic neurons innervating the vas deferens, seminal vesicle and coagulating gland.
    Wakade AR; Garcia AG; Kirpekar SM
    J Pharmacol Exp Ther; 1975 May; 193(2):424-34. PubMed ID: 1142099
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intracellular effects of estramustine (Estracyt/Emcyt).
    Tew KD; Stearns ME
    Prog Clin Biol Res; 1989; 303():169-75. PubMed ID: 2674983
    [No Abstract]   [Full Text] [Related]  

  • 49. The hydrolysis of estramustine phosphate; in vitro studies.
    Gunnarsson O; Andersson SB; Johansson SA
    Eur J Drug Metab Pharmacokinet; 1983; 8(4):395-402. PubMed ID: 6673977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of neonatal diethylstilbestrol treatment on androgen and estrogen receptor levels in the mouse anterior prostate, ventral prostate and seminal vesicle.
    Turner T; Edery M; Mills KT; Bern HA
    J Steroid Biochem; 1989 Apr; 32(4):559-64. PubMed ID: 2724959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro and in vivo effects of diethylstilbestrol and estramustine phosphate (Estracyt) on the mitogen responsiveness of human peripheral blood lymphocytes.
    Haukaas S; Høisaeter PA; Kalland T
    Prostate; 1982; 3(4):405-14. PubMed ID: 7122333
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The synthesis of 3H labelled steroid-nitrogen mustard derivatives and studies on their action in rat and human prostate.
    Symes EK; Milroy EJ
    J Steroid Biochem; 1982 Jul; 17(1):23-30. PubMed ID: 7109589
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative antitumor effects of hormonal ablation, estrogen agonist, estrogen cytotoxic derivative, and antiestrogen in the PAIII rat prostatic adenocarcinoma.
    Neubauer BL; Best KL; Goode RL; Heiman ML; Hoover DM; Robertson DW; Sarosdy MF; Shaar CJ; Tanzer LR; Merriman RL
    Cancer Res; 1992 Sep; 52(17):4663-71. PubMed ID: 1511432
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Experiences with estramustine phosphate (Estracyt, Emcyt) in prostate cancer.
    Murphy GP; Slack NH; Mittelman A
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):34-42. PubMed ID: 6364365
    [No Abstract]   [Full Text] [Related]  

  • 55. Metabolic aspects and actions unique to Estracyt.
    Sandberg AA
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):3-15. PubMed ID: 6364364
    [No Abstract]   [Full Text] [Related]  

  • 56. Influence of pituitary and adrenocortical hormones on prostatic secretion protein, a major protein in rat prostate.
    Pousette A; Björk P; Carlström K; Forsgren B; Högberg B; Gustafsson JA
    Prostate; 1982; 3(2):109-14. PubMed ID: 7088730
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estramustine phosphate vs diethylstilbestrol in the treatment of stage D prostate cancer.
    Benson RC; Cummings K
    Prog Clin Biol Res; 1989; 303():177-86. PubMed ID: 2674984
    [No Abstract]   [Full Text] [Related]  

  • 58. Interaction of the cytotoxic agent estramustine phosphate (Estracyt) with the estrogen receptor of the human uterus.
    Muechler EK; Kohler D
    Gynecol Oncol; 1979 Dec; 8(3):330-8. PubMed ID: 510999
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacokinetics and pharmacodynamics of estramustine phosphate.
    Bergenheim AT; Henriksson R
    Clin Pharmacokinet; 1998 Feb; 34(2):163-72. PubMed ID: 9515186
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intracellular localization of estramustine in rat ventral prostate in vitro.
    Peterson C; Björk P; Forsgren B; Högberg B
    Prostate; 1981; 2(2):143-54. PubMed ID: 6795611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.